Accuracy of Sentinel Lymph Node Biopsy in Nodal Staging of High Risk Endometrial Cancer

NACompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

June 21, 2019

Study Completion Date

September 30, 2021

Conditions
Endometrial CancerSentinel Lymph NodeIndocyanine Green
Interventions
BIOLOGICAL

Indocyanine Green (ICG)

ICG (Indocyanine Green) will be used as a fluorescent agent to identify sentinel lymph nodes intraoperatively. One 25 mg vial of ICG will be reconstituted in 10 mL of aqueous solvent (2.5 mg/mL). The solution will be injected at the 3 and 9 o'clock positions of the cervical stroma. 0.5 mL is injected superficially (submucosa) and 0.5 mL is injected deep (\~8mm) in the cervical stroma for a total injection volume of 2 mL.

Trial Locations (2)

M4N3M5

Sunnybrook Health Sciences Center, Toronto

M5T 2M9

University Health Network - Princess Margaret Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT01886066 - Accuracy of Sentinel Lymph Node Biopsy in Nodal Staging of High Risk Endometrial Cancer | Biotech Hunter | Biotech Hunter